Did you know that people with Parkinson's disease (PD) have a higher risk of fractures? The TOPAZ study will test if a medicine called zoledronic acid can prevent fractures in people with PD. A team of doctors who are experts in bone health and PD are leading the study. The use of zoledronic acid in this study is investigational.
Full Title
TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease
Status
Currently Enrolling
You can join if:
- You have Parkinson's disease
- Are 65 year old or older
What does participation involve?
- The study is done from your home!
- If you are eligible for the study, a nurse will come to your home to give you a short exam.
- You'll receive a one-time dose of either zoledronic acid or a placebo
- During the study, we will contact you every four months to check if you have had any new fractures
Earn $100 upon enrollment and $50 per year during the study.
Want to learn more about joining TOPAZ? Call the Parkinson's Foundation Helpline at 1-800-4PD-INFO (473-4636).
Ready to enroll? Visit www.topazstudy.org and enter FOUNDATION as your invitation code.
This study is endorsed by the Parkinson's Foundation and the Parkinson's Study Group.
Trial Phase
Phase 4
ClinicalTrial.gov ID
NCT03924414
My Navigator